Richard Shaw, Ph.D. , Scientist; Director of Clinical Informatics and Reporting at CPMC, Research Director of the Cardiology Fellowship Training Program

California Pacific CURRENTS: The online journal of CPMC Research Institute

Clinical informatics, statistical methods and analysis, and cardiovascular research
  • long-term effects of blood transfusion after CABG surgery

    The above graphic is from a study of the long-term effects of blood transfusion (and specifically different kinds of blood products used) on five-year survival after CABG surgery.

    Shaw RE, et al. Blood transfusion in cardiac surgery does increase the risk of 5-year mortality: results from a contemporary series of 1714 propensity-matched patients. Transfusion 2013 Aug 2. DOI: 10.1111/trf.12364. (Adapted from Figures 2 and 3) [Epub ahead of print]

  • four-year survival between patients who received coronary stents and those who underwent CABG surgery

    The authors compared four-year survival between patients who received coronary stents and those who underwent Coronary Artery Bypass Graft surgery (CABG), and used a technique called IPW that allowed matching patients who were similar in their presenting characteristics.  The graphic shows the Kaplan Meier Survival curves for both an unadjusted and adjusted analysis.

    Source: Weintraub WS, et al. Comparative Effectiveness of Revascularization Strategies. N Engl J Med 2012;366(16):1467-1476. (Figures 2 and 3) Copyright© (2014) Massachusetts Medical Society. Reprinted with permission from Massachusetts Medical Society.


Research Overview

  • Dr. Shaw leads medical research in database development and statistics.
  • His seminal work in creating a predictive risk model for percutaneous coronary intervention mortality led to the first clinical measure adopted by the National Quality Forum for interventional cardiology.
  • Dr. Shaw has published over 400 abstracts, articles, and book chapters on cardiac catheterization intervention, cardiac surgery, longitudinal assessment of medical outcomes, development of risk-adjustment models, and comparative effectiveness approaches to collecting medical information.
  • He is a consultant to cardiac programs in the U.S. and lectures on the development of cardiovascular research programs, statistical methods and analysis, design of medical databases, and risk adjustment methodology.


Dr. Shaw received his Ph.D. in Medical Research, Informatics, and Statistics from the Graduate Division and School of Medicine at the University of California, San Francisco, where he received the Robert E. Harris Award for Distinguished Research.


Publication Feed


Bates J, Parzynski CS, Dhruva SS, Coppi A, Kuntz R, Li SX, Marinac-Dabic D, Masoudi FA, Shaw RE, Warner F, Krumholz HM, Ross JS. Quantifying the utilization of medical devices necessary to detect postmarket safety differences: A case study of implantable cardioverter defibrillators. Pharmacoepidemiol Drug Saf.

Primary Research Interests
  • Clinical informatics for studying cardiovascular disease
  • Statistical methods and analysis of medical information
  • Design and development of medical databases